| 000 | 01842 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516080749.0 | ||
| 264 | 0 | _c20121119 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2012.50 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGianni, M | |
| 245 | 0 | 0 |
_ap38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells. _h[electronic resource] |
| 260 |
_bLeukemia _cAug 2012 |
||
| 300 |
_a1850-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 | _aGene Expression Regulation, Leukemic |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 14 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Stability |
| 650 | 0 | 4 |
_aReceptors, Retinoic Acid _xgenetics |
| 650 | 0 | 4 | _aRetinoic Acid Receptor alpha |
| 650 | 0 | 4 |
_aRetinoids _xpharmacology |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aPeviani, M | |
| 700 | 1 | _aBruck, N | |
| 700 | 1 | _aRambaldi, A | |
| 700 | 1 | _aBorleri, G | |
| 700 | 1 | _aTerao, M | |
| 700 | 1 | _aKurosaki, M | |
| 700 | 1 | _aParoni, G | |
| 700 | 1 | _aRochette-Egly, C | |
| 700 | 1 | _aGarattini, E | |
| 773 | 0 |
_tLeukemia _gvol. 26 _gno. 8 _gp. 1850-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2012.50 _zAvailable from publisher's website |
| 999 |
_c21563847 _d21563847 |
||